| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6176607 | European Urology | 2015 | 9 Pages |
Abstract
Predicting outcomes in men with newly diagnosed prostate cancer is challenging. This study demonstrates that a new molecular test, the Genomic Prostate Score, which can be performed on a patient's original prostate needle biopsy, can predict the aggressiveness of the cancer and help men make decisions regarding the need for immediate treatment of their cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jennifer Cullen, Inger L. Rosner, Timothy C. Brand, Nan Zhang, Athanasios C. Tsiatis, Joel Moncur, Amina Ali, Yongmei Chen, Dejan Knezevic, Tara Maddala, H. Jeffrey Lawrence, Phillip G. Febbo, Shiv Srivastava, Isabell A. Sesterhenn, David G. McLeod,